Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Kawasaki disease (kd) 2


Published on

  • Be the first to comment

  • Be the first to like this

Kawasaki disease (kd) 2

  1. 1. Kawasaki Disease (KD) <ul><li>Or mucocutaneous lymph node syndrome </li></ul><ul><li>Described first by Tomisaku Kawasaki in Japan, 1967. </li></ul><ul><li>An acute inflammatory syndrome that takes the form of systemic vasculitis, and predominantly affects children. </li></ul><ul><li>Important complications of this disease are coronary artery dilation and aneurysm formation. </li></ul>
  2. 2. Kawasaki Disease: Classic Characteristics <ul><li>Fever for 5 or more days </li></ul><ul><li>Presence of 4 of the following: </li></ul><ul><ul><li>Bilateral conjunctival injection </li></ul></ul><ul><ul><li>Changes in the oropharyngeal mucous membranes </li></ul></ul><ul><ul><li>Changes of the peripheral extremities </li></ul></ul><ul><ul><li>Rash </li></ul></ul><ul><ul><li>Cervical adenopathy </li></ul></ul><ul><li>Coronary artery aneurysms or ectasia: 15-25% of those untreated </li></ul><ul><ul><li>Myocardial infarction, sudden death, ischemic cardiac disease </li></ul></ul><ul><ul><li>Illness can’t be explained by other disease </li></ul></ul>
  3. 3. clinical features of Kawasaki disease Peeling and erythema of the fingertips. Strawberry tongue.
  4. 4. Pathophysiology <ul><li>The etiology of Kawasaki disease remains unknown , although many suspect an infectious etiology. </li></ul><ul><li>the self-limited nature; the winter and summer presentations; and the characteristic fever, adenopathy, and eye signs. </li></ul><ul><li>many factors (viruses, staphylococci &quot;super antigens&quot;) : triggering a final common pathway that results in immune activation. </li></ul><ul><li>May be related to a genetic predisposition to genetic polymorphisms. </li></ul>
  5. 5. Causes <ul><li>Multiple theories exist : </li></ul><ul><ul><li>An infectious etiology. </li></ul></ul><ul><ul><li>an immunological abnormality. </li></ul></ul><ul><ul><li>Clinical and epidemiologic features support an infectious etiology, but many authorities believe that an autoimmune component also exists. </li></ul></ul>
  6. 6. Pathology <ul><li>The media of affected vessels demonstrate edematous dissociation of the smooth muscle cells. </li></ul><ul><li>Endothelial cell swelling & subendothelial edema are seen (but the internal elastic lamina remains intact). </li></ul><ul><li>An influx of neutrophils is found in the early stages (7 to 9 days after onset) , also Lymphocytes and IgA plasma cells. </li></ul>
  7. 7. Pathology <ul><li>Destruction of the internal elastic lamina and eventually fibroblastic proliferation. </li></ul><ul><li>Matrix metallo proteinases (MMP) are prominent in the remodeling process. </li></ul><ul><li>Active inflammation is replaced over several weeks to months by progressive fibrosis, with scar formation. </li></ul><ul><li>Active remodeling with intimal proliferation and neoangiogenesis. </li></ul>
  8. 8. Pathogenesis
  9. 9. Pathogenesis
  10. 10. Pathogenesis Proposed role of S100 proteins (myeloid-related protein [MRP]-8, MRP-14, and S100A12) in the genesis and maintenance of the vasculitis in Kawasaki disease.
  11. 11. Pathogenesis The net result of S100 protein binding is platelet aggregation and adherence to endothelium.
  12. 12. Complications <ul><ul><li>Symptoms often disappear within just 2 days of the start of treatment. </li></ul></ul><ul><ul><li>ภาวะแทรกซ้อนที่อาจเกิดขึ้นในกรณีที่ไม่ได้รับการรักษา มีโอกาสเกิด coronary artery aneurysm ได้ร้อยละ 20 </li></ul></ul><ul><ul><li>Serious complications : </li></ul></ul><ul><ul><ul><li>vasculitis </li></ul></ul></ul><ul><ul><ul><ul><li>affect the coronary arteries, which supply blood to the heart. </li></ul></ul></ul></ul><ul><ul><ul><ul><li>Arrhythmias or abnormal functioning of some heart valves also can occur. </li></ul></ul></ul></ul>
  13. 13. Complications <ul><li>Depressed myocardial contractility . </li></ul><ul><li>Giant coronary artery aneurysms. </li></ul><ul><li>Peripheral arterial obstruction . </li></ul><ul><li>Serum lipid abnormalities. </li></ul><ul><li>Renal disease and urinary abnormalities. </li></ul><ul><li>Noncoronary vascular involvement. </li></ul><ul><li>Macrophage activation syndrome. </li></ul>
  14. 14. Treatment <ul><li>Treatment should begin as soon as possible, ideally within 10 days of when the fever begins . </li></ul><ul><li>Admit to monitor cardiac function </li></ul><ul><li>Complete cardiac evaluation </li></ul><ul><ul><li>CXR, EKG, echo </li></ul></ul><ul><li>gamma globulin (purified antibodies), an ingredient of blood that helps the body fight infection. </li></ul><ul><li>The child also might be given a high dose of aspirin to reduce the risk of heart problems. </li></ul>
  15. 15. Treatment <ul><li>Aspirin </li></ul><ul><ul><li>High dose initially: 80 – 100 mg/kg/day in 4 doses </li></ul></ul><ul><ul><li>Low dose: 3 – 5 mg/kg/day </li></ul></ul><ul><li>• IVIG </li></ul><ul><ul><li>2 g/kg as single infusion ( within 10 -12 hr.) </li></ul></ul><ul><ul><li>Treat within 10 days of onset of symptoms </li></ul></ul>
  16. 16. Risks of Treatment <ul><li>• IVIG </li></ul><ul><li>– Flushing, hypotension, chills, fever, headache, low back pain, nausea, chest tightness </li></ul><ul><li>– Rare: aseptic meningitis, neutropenia, elevated creatinine, hemolytic anemia </li></ul><ul><li>– IgA deficient patients at risk for anaphylaxis </li></ul><ul><li>– Risks of blood product </li></ul><ul><li>Aspirin </li></ul><ul><li> – Concern for Reye syndrome </li></ul>
  17. 17. References <ul><li>http:// . </li></ul><ul><li> </li></ul><ul><li> </li></ul><ul><li> </li></ul><ul><li> </li></ul><ul><li>http:// % 20 Disease </li></ul><ul><li> </li></ul><ul><li> </li></ul>